![Maria Palasis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Palasis
Chief Executive Officer at
LYRA THERAPEUTICS, INC.
Net worth: 1 M $ as of 2026-05-30
Profile
Maria Palasis is Chief Executive Officer & Director at Lyra Therapeutics, Inc. since 2026.
Dr. Palasis is Director at PanTher Therapeutics, Inc. Dr. Palasis is Director at Medexecwomen.
Dr. Palasis is Independent Director at Beta Bionics, Inc. since 2025.
Formerly, Dr. Palasis was President, Chief Executive Officer & Director at Arsenal Medical, Inc. from 2015 to 2018.
Dr. Palasis was Director at Boston Scientific Corp.
from 1995 to 2008.
Dr. Palasis was Director at Beta Bionics, Inc. from 2022 to 2023.
Education includes undergraduate and doctorate degrees from the University of Cincinnati (Ohio).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LYRA THERAPEUTICS, INC. 61.68% | 2026-03-31 | 1,094,733 ( 61.68% ) | 810 102 $ | 2026-05-30 |
BETA BIONICS, INC. 0.07% | 2026-05-20 | 29,397 ( 0.07% ) | 356 292 $ | 2026-05-30 |
BETA BIONICS, INC. -.--% | 2025-01-28 | 0 ( -.--% ) | - $ | 2026-05-30 |
Maria Palasis active positions
| Companies | Position | Start |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Chief Executive Officer | 2014-12-31 |
| BETA BIONICS, INC. | Director/Board Member | 2024-12-31 |
PanTher Therapeutics, Inc.
 PanTher Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Director/Board Member | - |
Medexecwomen | Director/Board Member | - |
Former positions of Maria Palasis
| Companies | Position | End |
|---|---|---|
| BETA BIONICS, INC. | Director/Board Member | 2023-08-31 |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Medical SpecialtiesHealth Technology Develops biomaterials provides local therapy for important medical conditions across therapeutic areas | Chief Executive Officer | 2018-05-31 |
| BOSTON SCIENTIFIC CORPORATION | Director/Board Member | 2007-12-31 |
Training of Maria Palasis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Arsenal Medical, Inc.
Arsenal Medical, Inc. Medical SpecialtiesHealth Technology Develops biomaterials provides local therapy for important medical conditions across therapeutic areas | Health Technology |
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
PanTher Therapeutics, Inc.
PanTher Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Medexecwomen | Commercial Services |
- Stock Market
- Insiders
- Maria Palasis
Choose MarketScreener 
